Ziółkowska Ewa, Zarzycka Małgorzata, Wiśniewski Tomasz, Zyromska Agnieszka
Department of Radiotherapy I, Oncology Centre - prof. Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland.
Contemp Oncol (Pozn). 2012;16(6):491-7. doi: 10.5114/wo.2012.32478. Epub 2013 Jan 4.
Prostate cancer is one of most frequent malignant tumours at men. The androgen-deprivation therapy is the part of cancer treatment. It could be used both in the early stage of prostate cancer and in the bone metastates. From this reason the antiandrogen drugs waste systematically grows. Unfortunately androgen-deprivation therapy has numerous side effects such as: the inferior quality of live, sexual disturbances, the fatigue, the anaemia, the bone mineral density loss and the increase of the risk of breaks the bone, the increase of body mass, insulinresistance, hypercholesterolemia, the increase risk of cardiac disorders. The aim of this article is the introduction of the reader with possibly complications androgen-deprivation therapy and with possibilities in diagnosis and treatment.
前列腺癌是男性中最常见的恶性肿瘤之一。雄激素剥夺疗法是癌症治疗的一部分。它可用于前列腺癌的早期阶段以及骨转移阶段。因此，抗雄激素药物的消耗量在系统性地增长。不幸的是，雄激素剥夺疗法有许多副作用，如生活质量下降、性功能障碍、疲劳、贫血、骨矿物质密度丧失和骨折风险增加、体重增加、胰岛素抵抗、高胆固醇血症、心脏疾病风险增加。本文的目的是向读者介绍雄激素剥夺疗法可能出现的并发症以及诊断和治疗的可能性。
